{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T11:58:35Z","timestamp":1700567915546},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Hematology"],"published-print":{"date-parts":[[2007,8,1]]},"DOI":"10.1532\/ijh97.07022","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T16:22:02Z","timestamp":1190132522000},"page":"147-149","source":"Crossref","is-referenced-by-count":4,"title":["t(6;14)(q15;q32) in a Patient with CD5+CD10+ Diffuse Large B-Cell Lymphoma"],"prefix":"10.1007","volume":"86","author":[{"given":"Miyuki","family":"Hayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomi","family":"Niitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Higashihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Nakamine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuo","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"E00001","unstructured":"Yamaguchi M, Seto M, Okamoto M, et al. De novo CD5+ diffuse large B-cell lymphoma: clinicopathologic study of 109 patients. <i>Blood.<\/i> 2002;99:815-821."},{"key":"E00002","unstructured":"Dong HY, Gorczyca W, Liu Z, et al. B-cell lymphoma with coexpression of CD5 and CD10. <i>Am J Clin Pathol.<\/i> 2003;119:218-230."},{"key":"E00003","doi-asserted-by":"crossref","unstructured":"Grillo-Lopez AJ. Monoclonal antibody therapy for B-cell lymphoma. <i>Int J Hematol.<\/i> 2002;76:385-393.","DOI":"10.1007\/BF02982803"},{"key":"E00004","unstructured":"Tagawa H, Tsuzuki S, Suzuki R, et al. Genome-wide array-based comparative genomic hybridization of diffuse large B-cell lymphoma: comparison between CD5-positive and CD5-negative cases. <i>Cancer Res.<\/i> 2004;64:5948-5955."},{"key":"E00005","unstructured":"Yoshioka T, Miura I, Kume M, et al. Cytogenetic features of de novo CD5-positive diffuse large B-cell lymphoma: chromosome aberrations affecting 8p21 and 11q13 constitute major subgroups with different overall survival. <i>Genes Chromosomes Cancer.<\/i> 2005;42:149-157."},{"key":"E00006","unstructured":"Karnan S, Tagawa H, Suzuki R, et al. Analysis of chromosomal imbalances in de novo CD5-positive diffuse large-B-cell lymphoma detected by comparative genomic hybridization. <i>Genes Chromosomes Cancer.<\/i> 2004;39:77-81."},{"key":"E00007","unstructured":"Reeves BR, Pickup VL. The chromosome change in non-Burkitt lymphomas. <i>Hum Genet.<\/i> 1980;53:349-355."},{"key":"E00008","unstructured":"Wu SQ, Kou J, Chen XR, et al. Translocation (6;14) in childhood acute mixed lineage leukemia. <i>Cancer Genet Cytogenet.<\/i> 2003;141:178-179."},{"key":"E00009","unstructured":"Itoyama T, Sadamori N, Tsutsumi K, et al. Primary central nervous system lymphomas. <i>Cancer.<\/i> 1994;73:455-463."},{"key":"E00010","unstructured":"Jerkeman M, Johansson B, Akerman M, et al. Prognostic implications of cytogenetic aberrations in diffuse large B-cell lymphomas. <i>Eur J Haematol.<\/i> 1999;62:184-190."},{"key":"E00011","unstructured":"Kanno H, Yasunaga Y, Ohsawa M, et al. Expression of Epstein-Barr virus latent infection genes and oncogenes in lymphoma cell lines derived from pyothorax-associated lymphoma. <i>Int J Cancer.<\/i> 1996;67:86-94."},{"key":"E00012","unstructured":"Albagli O, Dhordain P, Deweindt C, Lecocq G, Leprince D. The BTB\/POZ domain: a new protein-protein interaction motif common to DNA- and actin-binding proteins. <i>Cell Growth Differ.<\/i> 1995;6:1193-1198."},{"key":"E00013","unstructured":"Sasaki S, Ito E, Toki T, et al. Cloning and expression of human B cell-specific transcription factor BACH2 mapped to chromosome 6q15. <i>Oncogene.<\/i> 2000;19:3739-3749."},{"key":"E00014","unstructured":"Sakane-Ishikawa E, Nakatsuka S, Tomita Y, et al. Prognostic significance of BACH2 expression in diffuse large B-cell lymphoma: a study of the Osaka Lymphoma Study Group. <i>J Clin Oncol.<\/i> 2005;23:8012-8017."},{"key":"E00015","unstructured":"Takakuwa T, Wen-Juan Luo M, Francisca H, et al. Integration of Epstein-Barr virus into chromosome 6q15 of Burkitt lymphoma cell line (Raji) induces loss of <i>BACH2<\/i> expression. <i>Amer J Pathol.<\/i> 2004;164:967-974."},{"key":"E00016","unstructured":"Muto A, Tashiro S, Tsuchiya H, et al. Activation of Maf\/AP-1 Repressor Bach2 by oxidative stress promotes apoptosis and its interaction with promyelocytic leukemia nuclear bodies. <i>J Biol Chem.<\/i> 2002;277:20724-20733."},{"key":"E00017","unstructured":"Kamio T, Toki T, Kanezaki R, et al. The B cell-specific transcription factor BACH2 modifies the cytotoxic effects of anticancer dugs. <i>Blood.<\/i> 2003;102:3317-3322."}],"container-title":["International Journal of Hematology"],"original-title":[],"link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1532\/IJH97.07022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T03:19:28Z","timestamp":1556853568000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1532\/IJH97.07022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,1]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,8,1]]}},"alternative-id":["3611X86W012213X0"],"URL":"https:\/\/doi.org\/10.1532\/ijh97.07022","relation":{},"ISSN":["0925-5710"],"issn-type":[{"value":"0925-5710","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8,1]]}}}